Market Impact of COVID-19 on Life Sciences Industry - Opportunities and Obstacles
Report ID: 392116 | May 2020 | No. of Pages: 120
|
Covid-19 Impact Analysis & Forecast
COVID-19 Impact on Life Science Industry By Key Manufacturers, By Type (Healthcare IT, Analytical and Scientific Instrumentation, Pharmaceuticals (Clinical Diagnostics, Sales and Marketing, Drug Development, Therapeutic/drugs, Niche Applications, Healthcare), Medical Devices (Diagnostic Imaging, Drug Delivery Devices, Minimally-invasive/Non-Invasive Surgery, Therapeutic, Molecular Diagnostic, Mobility Aid Technologies, Microfluids & MEMS, Non-Invasive monitoring, Bioimplants - Neurostimulators), Biotechnology (Biomaterials, Proteomics, Bioinformatics, Biomarkers, Biosimilars, Drug Delivery, Drug Discovery, Stem Cell, RNAi, Genomics, Biomanufacturing)) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Global Life Science Industry size is estimated to record USD XX billion by 2026, at a Compound Annual Growth Rate (CAGR) of XX%.
Life Science Industry report (2019-2026) includes global market size, trends, company overview, competition analysis, and forecast. The global market is projected to record USD XX Billion in 2019.
The market report includes Life Science Industry definition, segmentation, executive summary, value chain analysis, porter’s analysis, research methodology and new industry trends which includes drivers, restraints and market opportunities. Other section includes regional analysis which is conducted on various factors such as cost of the product/services, raw material supplies, production capacities, availability and demand analysis. Further section includes analysis and opportunity assessment for key companies. This section includes competition analysis, market share analysis, key developments of the industry, and company profiling. Within company profiling, detailed analysis of key players including company overview, financial information analysis, product offerings, and recent development of company. This also includes SWOT analysis that highlights the current position of company among competitors and in market.
Life Science Industry Dynamics
The market report comprises of market dynamics/trends section that includes driving factors, restraints, and opportunities faced by the market players and stakeholders. These market trends includes core factors such as driving factor and restraining factor and extrinsic factors such as opportunities. These factors are not only confined with the current market situation as well as with the forecasted period.
Life Science Industry Competitive Landscape
The key companies in Life Science Industry are Johnson & Johnson, Roche, United Health Group, Merck, Pfizer, Novartis, Abbott, Medtronic, Novo Nordisk, Amgen Inc.
Focus Areas of Market
• Global Market Analysis (2019-2026)
• Cost Analysis
• Market Growth Factors
• Market Strategies
• Key Companies Analysis
• Industry Growth Analysis
Regional Analysis
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Company Profile Inclusions
• Business Overview
• Financial Information
• Market Share Analysis
• Recent News
• SWOT Analysis
Global Life Science Industry size is estimated to record USD XX billion by 2026, at a Compound Annual Growth Rate (CAGR) of XX%.
Life Science Industry report (2019-2026) includes global market size, trends, company overview, competition analysis, and forecast. The global market is projected to record USD XX Billion in 2019.
The market report includes Life Science Industry definition, segmentation, executive summary, value chain analysis, porter’s analysis, research methodology and new industry trends which includes drivers, restraints and market opportunities. Other section includes regional analysis which is conducted on various factors such as cost of the product/services, raw material supplies, production capacities, availability and demand analysis. Further section includes analysis and opportunity assessment for key companies. This section includes competition analysis, market share analysis, key developments of the industry, and company profiling. Within company profiling, detailed analysis of key players including company overview, financial information analysis, product offerings, and recent development of company. This also includes SWOT analysis that highlights the current position of company among competitors and in market.
Life Science Industry Dynamics
The market report comprises of market dynamics/trends section that includes driving factors, restraints, and opportunities faced by the market players and stakeholders. These market trends includes core factors such as driving factor and restraining factor and extrinsic factors such as opportunities. These factors are not only confined with the current market situation as well as with the forecasted period.
Life Science Industry Competitive Landscape
The key companies in Life Science Industry are Johnson & Johnson, Roche, United Health Group, Merck, Pfizer, Novartis, Abbott, Medtronic, Novo Nordisk, Amgen Inc.
Focus Areas of Market
• Global Market Analysis (2019-2026)
• Cost Analysis
• Market Growth Factors
• Market Strategies
• Key Companies Analysis
• Industry Growth Analysis
Regional Analysis
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Company Profile Inclusions
• Business Overview
• Financial Information
• Market Share Analysis
• Recent News
• SWOT Analysis
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
Chapter 5. Life Science Industry Industry, By Type
5.1. Life Science Industry, By Type 2019-2026
5.2. Healthcare IT
5.3. Analytical and Scientific Instrumentation
5.4. Pharmaceuticals
5.4.1. Clinical Diagnostics
5.4.2. Sales and Marketing
5.4.3. Drug Development
5.4.4. Therapeutic/drugs
5.4.5. Niche Applications
5.4.6. Healthcare
5.5. Medical Devices
5.5.1. Diagnostic Imaging
5.5.2. Drug Delivery Devices
5.5.3. Minimally-invasive/Non-Invasive Surgery
5.5.4. Therapeutic
5.5.5. Molecular Diagnostic
5.5.6. Mobility Aid Technologies
5.5.7. Microfluids & MEMS
5.5.8. Non-Invasive monitoring
5.5.9. Bioimplants - Neurostimulators
5.6. Biotechnology
5.6.1. Biomaterials
5.6.2. Proteomics
5.6.3. Bioinformatics
5.6.4. Biomarkers
5.6.5. Biosimilars
5.6.6. Drug Delivery
5.6.7. Drug Discovery
5.6.8. Stem Cell
5.6.9. RNAi
5.6.10. Genomics
5.6.11. Biomanufacturing
Chapter 6. Life Science Industry Industry, By Region
6.1. Life Science Industry, By Region 2019-2026
6.1.1. North America
6.1.1.1. U.S
6.1.1.1. Canada
6.1.1.2. Mexico
6.1.2. Europe
6.1.2.1. U.K.
6.1.2.2. Germany
6.1.2.3. France
6.1.2.4. Rest of the Europe
6.1.3. Middle East & Africa (MEA)
6.1.3.1. GCC
6.1.3.2. North Africa
6.1.3.3. South Africa
6.1.3.4. Rest of MEA
6.1.4. Latin America (LATAM)
6.1.4.1. Brazil
6.1.4.2. Rest of LATAM
6.1.5. Asia Pacific (APAC)
6.1.5.1. India
6.1.5.2. China
6.1.5.3. Japan
6.1.5.4. Rest of the APAC
Chapter 7. Competitive Landscape
7.1.1. Key Strategies Adopted by Players
7.1.2. Market Share/Positioning Analysis7
Chapter 8. Company Profiles
8.1. Johnson & Johnson
8.1.1. Company Overview
8.1.2. Product Offerings
8.1.3. Financial Performance
8.1.4. Recent Initiatives
8.2. Roche
8.3. United Health Group
8.4. Merck
8.5. Pfizer
8.6. Novartis
8.7. Abbott
8.8. Medtronic
8.9. Novo Nordisk
8.10. Amgen Inc
Chapter 9. Appendix
9.1. About Us
9.2. Glossary of Terms
9.3. Disclaimer
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
Chapter 5. Life Science Industry Industry, By Type
5.1. Life Science Industry, By Type 2019-2026
5.2. Healthcare IT
5.3. Analytical and Scientific Instrumentation
5.4. Pharmaceuticals
5.4.1. Clinical Diagnostics
5.4.2. Sales and Marketing
5.4.3. Drug Development
5.4.4. Therapeutic/drugs
5.4.5. Niche Applications
5.4.6. Healthcare
5.5. Medical Devices
5.5.1. Diagnostic Imaging
5.5.2. Drug Delivery Devices
5.5.3. Minimally-invasive/Non-Invasive Surgery
5.5.4. Therapeutic
5.5.5. Molecular Diagnostic
5.5.6. Mobility Aid Technologies
5.5.7. Microfluids & MEMS
5.5.8. Non-Invasive monitoring
5.5.9. Bioimplants - Neurostimulators
5.6. Biotechnology
5.6.1. Biomaterials
5.6.2. Proteomics
5.6.3. Bioinformatics
5.6.4. Biomarkers
5.6.5. Biosimilars
5.6.6. Drug Delivery
5.6.7. Drug Discovery
5.6.8. Stem Cell
5.6.9. RNAi
5.6.10. Genomics
5.6.11. Biomanufacturing
Chapter 6. Life Science Industry Industry, By Region
6.1. Life Science Industry, By Region 2019-2026
6.1.1. North America
6.1.1.1. U.S
6.1.1.1. Canada
6.1.1.2. Mexico
6.1.2. Europe
6.1.2.1. U.K.
6.1.2.2. Germany
6.1.2.3. France
6.1.2.4. Rest of the Europe
6.1.3. Middle East & Africa (MEA)
6.1.3.1. GCC
6.1.3.2. North Africa
6.1.3.3. South Africa
6.1.3.4. Rest of MEA
6.1.4. Latin America (LATAM)
6.1.4.1. Brazil
6.1.4.2. Rest of LATAM
6.1.5. Asia Pacific (APAC)
6.1.5.1. India
6.1.5.2. China
6.1.5.3. Japan
6.1.5.4. Rest of the APAC
Chapter 7. Competitive Landscape
7.1.1. Key Strategies Adopted by Players
7.1.2. Market Share/Positioning Analysis7
Chapter 8. Company Profiles
8.1. Johnson & Johnson
8.1.1. Company Overview
8.1.2. Product Offerings
8.1.3. Financial Performance
8.1.4. Recent Initiatives
8.2. Roche
8.3. United Health Group
8.4. Merck
8.5. Pfizer
8.6. Novartis
8.7. Abbott
8.8. Medtronic
8.9. Novo Nordisk
8.10. Amgen Inc
Chapter 9. Appendix
9.1. About Us
9.2. Glossary of Terms
9.3. Disclaimer
1. Johnson & Johnson
2. Roche
3. United Health Group
4. Merck
5. Pfizer
6. Novartis
7. Abbott
8. Medtronic
9. Novo Nordisk
10. Amgen Inc
2. Roche
3. United Health Group
4. Merck
5. Pfizer
6. Novartis
7. Abbott
8. Medtronic
9. Novo Nordisk
10. Amgen Inc
Connect With Us
+1-707-633-0404
sales@search4research.com
Related reports
|
|
(COVID Version) Global Cotton Buds Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 105
|
$3000Buy Now |
|
|
(COVID Version) Global Cotton Balls and Swabs Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 110
|
$3000Buy Now |
|
|
(COVID Version) Global Cosmetic Surgery Equipment Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 108
|
$3000Buy Now |
|
|
(COVID Version) Global Cosmetic Prostheses Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 100
|
$3000Buy Now |
|
|
(COVID Version) Global Cortisone Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 103
|
$3000Buy Now |